DIO2-AS1: A Potential Drug Target and Biomarker (G100628307)

Target Name: DIO2-AS1

NCBI ID: G100628307

Other Name(s): DIO2 antisense RNA 1

DIO2-AS1: A Potential Drug Target and Biomarker

The identification of potential drug targets and biomarkers is a crucial step in the development of new pharmaceuticals. DIO2-AS1, a protein expressed in various tissues of the body, has been identified as a potential drug target and biomarker. This protein plays a crucial role in the regulation of cell growth, differentiation, and survival, and its dysfunction has been linked to various diseases, including cancer.

DIO2-AS1: Structure and Function

DIO2-AS1 is a member of the Asparagine-Water-Asparagine (A-WAS) domain family, which is a common structural feature in proteins that are involved in various cellular processes, including cell signaling, cell adhesion, and tissue repair. The A-WAS domain is responsible for the formation of a specific hydrogen bonding pattern in the protein sequence, which is important for its stability and functions as a protein.

DIO2-AS1 functions as a negative regulator of the cell cycle, specifically in the G1 phase. It promotes the G1/S transition by inhibiting the activity of the G1-specific protein, p21 (CDK4), which is involved in cell growth and division. DIO2-AS1 also inhibits the activity of the S-phase protein, p22 (CDK6), which is involved in the completion of DNA replication. These inhibitions result in the accumulation of G1-specific and S-phase proteins in the cell, leading to the G1/S transition.

DIO2-AS1 has also been shown to play a role in the regulation of cell survival and apoptosis. It has been shown to promote the survival of cancer cells by inhibiting the activity of p53, a protein that is involved in cell apoptosis. Additionally, DIO2-AS1 has been shown to promote the growth of cancer cells by activating the A-WAS domain-containing protein, p16 (CDK4), which is involved in cell growth and survival.

DIO2-AS1 as a Potential Drug Target

The identification of DIO2-AS1 as a potential drug target is based on its involvement in the regulation of cell cycle and cell survival. DIO2-AS1 has been shown to promote the growth and survival of cancer cells, making it an attractive target for cancer therapies.

One of the main advantages of DIO2-AS1 as a drug target is its specificity. Unlike many other potential drug targets, DIO2-AS1 has a clear and well-defined function, making it easier to develop new treatments. Additionally, DIO2-AS1 has been shown to play a role in the regulation of cell cycle and cell survival, which are crucial processes in cancer development.

Another advantage of DIO2-AS1 as a drug target is its availability. DIO2-AS1 is expressed in various tissues of the body, including human tissues, making it an attractive target for drugs that can be administered to patients without significant side effects.

DIO2-AS1 as a Potential Biomarker

DIO2-AS1 has also been identified as a potential biomarker for various diseases, including cancer. The regulation of cell cycle and cell survival by DIO2-AS1 is known to be disrupted in various diseases, including cancer.

One of the main potential benefits of DIO2-AS1 as a biomarker is its ability to be used as a diagnostic tool. By measuring the levels of DIO2-AS1 in cancer cells or tissues, researchers can monitor the effectiveness of new treatments and determine the impact of disease progression. Additionally, DIO2-AS1 has been shown to be downregulated in various

Protein Name: DIO2 Antisense RNA 1

More Common Targets